| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.017 | 0.9 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |